These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34830599)

  • 1. Diabetes Mellitus in Prader-Willi Syndrome: Natural History during the Transition from Childhood to Adulthood in a Cohort of 39 Patients.
    Clerc A; Coupaye M; Mosbah H; Pinto G; Laurier V; Mourre F; Merrien C; Diene G; Poitou C; Tauber M
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
    Crinò A; Grugni G
    Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric behavioral effect and characteristics of type 2 diabetes mellitus on Japanese patients with Prader-Willi syndrome: a preliminary retrospective study.
    Oto Y; Murakami N; Inoue T; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):89-96. PubMed ID: 34792304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome.
    Paepegaey AC; Coupaye M; Jaziri A; Ménesguen F; Dubern B; Polak M; Oppert JM; Tauber M; Pinto G; Poitou C
    Endocr Connect; 2018 May; 7(5):663-672. PubMed ID: 29666169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A questionnaire-based survey of medical conditions in adults with Prader-Willi syndrome in Japan: implications for transitional care.
    Kawai M; Muroya K; Murakami N; Ihara H; Takahashi Y; Horikawa R; Ogata T
    Endocr J; 2023 May; 70(5):519-528. PubMed ID: 36792176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic health profile in young adults with Prader-Willi syndrome: results of a 2-year randomized, placebo-controlled, crossover GH trial.
    Kuppens RJ; Bakker NE; Siemensma EP; Donze SH; Stijnen T; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2017 Feb; 86(2):297-304. PubMed ID: 27689944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early adiposity rebound in patients with Prader-Willi syndrome.
    Oto Y; Murakami N; Matsubara K; Ogata H; Ihara H; Matsubara T; Nagai T
    J Pediatr Endocrinol Metab; 2018 Dec; 31(12):1311-1314. PubMed ID: 30407912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
    Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of Prader-Willi syndrome: the endocrine approach.
    Heksch R; Kamboj M; Anglin K; Obrynba K
    Transl Pediatr; 2017 Oct; 6(4):274-285. PubMed ID: 29184809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine and Metabolic Illnesses in Young Adults with Prader-Willi Syndrome.
    Noh ES; Kim MS; Kim C; Jeon K; Kim S; Cho SY; Jin DK
    J Pers Med; 2022 May; 12(6):. PubMed ID: 35743643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
    Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
    Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment.
    Nagai T; Obata K; Tonoki H; Temma S; Murakami N; Katada Y; Yoshino A; Sakazume S; Takahashi E; Sakuta R; Niikawa N
    Am J Med Genet A; 2005 Jul; 136(1):45-8. PubMed ID: 15937939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome.
    Rigamonti AE; Crinò A; Bocchini S; Convertino A; Bidlingmaier M; Haenelt M; Tamini S; Cella SG; Grugni G; Sartorio A
    Growth Horm IGF Res; 2018 Apr; 39():13-18. PubMed ID: 29217318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report.
    Candler T; McGregor D; Narayan K; Moudiotis C; Burren CP
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):951-955. PubMed ID: 32447330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.